by Eric Christianson | Sep 15, 2021 | Educational Case Studies For Pharmacists
LT is a 67-year-old white male presenting to your ambulatory care clinic for a CMR. He says his wife tells him he is taking too many medications and he wants your help evaluating his current regimen. According to his chart, his blood pressure has been within goal, but...
by Eric Christianson | Sep 1, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
At the end of July, the FDA approved Semglee (insulin glargine-yfgn) as the first-ever interchangeable drug in the United States. It is essentially a copy of Lantus, a long-acting basal insulin. Patients will have questions about the interchangeable status of...
by Eric Christianson | Jul 28, 2021 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
While Dipeptidyl Peptidase-4 (DPP4) inhibitors aren’t used incredibly often, we wanted to provide a comparison of DPP4 inhibitors. DPP4 inhibitors are used in the treatment of diabetes and function by inhibiting the breakdown of endogenous incretin hormones...
by Eric Christianson | Feb 14, 2021 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Technology continues to impact disease state management in remarkable ways. Monitoring of patients with diabetes is no exception. Both the American Diabetes Association and American Association of Clinical Endocrinologists/American College of Endocrinology make light...
by Eric Christianson | Dec 16, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists, Polypharmacy Cases And The Prescribing Cascade
SGLT2s like empagliflozin, dapagliflozin, ertugliflozin, and canagliflozin are getting more use in diabetes care as time goes on. As a geriatric pharmacist, I certainly recognize that these agents have a lot of potential benefits, but they can also have adverse...
